Shrenik Mehta

790 total citations
18 papers, 617 citations indexed

About

Shrenik Mehta is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Shrenik Mehta has authored 18 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Molecular Medicine and 4 papers in Infectious Diseases. Recurrent topics in Shrenik Mehta's work include Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Shrenik Mehta is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Shrenik Mehta collaborates with scholars based in United States, France and Japan. Shrenik Mehta's co-authors include Timothy Palzkill, Adriana E. Rosato, Sarah Riosa, Konrad Plata, Roberto R. Rosato, Palas K. Chanda, Christopher R. Singh, Jared Silverman, Katherine K. Perez and Aileen Rubio and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Scientific Reports.

In The Last Decade

Shrenik Mehta

18 papers receiving 604 citations

Peers

Countries citing papers authored by Shrenik Mehta

Since Specialization

Citations

This map shows the geographic impact of Shrenik Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrenik Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrenik Mehta more than expected).

Fields of papers citing papers by Shrenik Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shrenik Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrenik Mehta. The network helps show where Shrenik Mehta may publish in the future.

Co-authorship network of co-authors of Shrenik Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Shrenik Mehta. A scholar is included among the top collaborators of Shrenik Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shrenik Mehta. Shrenik Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A Mechanistic Understanding of Monoclonal Antibody Interfacial Protection by Hydrolytically Degraded Polysorbate 20 and 80 under IV Bag Conditions 2022 ·Pharmaceutical Research ·Aadithya Kannan, (unknown), Shrenik Mehta, Tiffany Lin, Anthony A. G. Tomlinson, (unknown), Ian C. Shieh, Miguel Saggu, (unknown)	11
2	Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species 2022 ·mAbs ·(unknown), Aaron T. Wecksler, Baikuntha Aryal, Shrenik Mehta, Melissa A. Pegues, (unknown), (unknown), (unknown), Alavattam Sreedhara, V. Ashutosh Rao	16
3	Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms 2022 ·mAbs ·Elizabeth S. Hecht, Shrenik Mehta, Aaron T. Wecksler, (unknown), (unknown), Wilson Phung, (unknown), W. Henry Benner, Devin B. Tesar, Robert F. Kelley, Wendy Sandoval, Alavattam Sreedhara	14
4	Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies 2021 ·Pharmaceutical Research ·Shrenik Mehta, (unknown), Benjamin T. Walters, Alavattam Sreedhara	11
5	Local interactions with the Glu166 base and the conformation of an active site loop play key roles in carbapenem hydrolysis by the KPC-2 β-lactamase 2021 ·Journal of Biological Chemistry ·(unknown), Shrenik Mehta, Banumathi Sankaran, Liya Hu, B. V. Venkataram Prasad, Timothy Palzkill	17
6	KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate 2020 ·Journal of Biological Chemistry ·Shrenik Mehta, (unknown), O.A. Pemberton, (unknown), Yu Chen, Timothy Palzkill	27
7	Protein conjugates and fusion proteins as ocular therapeutics 2019 ·Drug Discovery Today ·Shrenik Mehta, Robert F. Kelley, Devin B. Tesar	8
8	Lead Optimization Yields High Affinity Frizzled 7-Targeting Peptides That Modulate Clostridium difficile Toxin B Pathogenicity in Epithelial Cells 2019 ·Journal of Medicinal Chemistry ·Simon Hansen, Aaron H. Nile, Shrenik Mehta, Jakob Fuhrmann, Rami N. Hannoush	10
9	Deep Sequencing of Random Mutant Libraries Reveals the Active Site of the Narrow Specificity CphA Metallo-β-Lactamase is Fragile to Mutations 2016 ·Scientific Reports ·Zhizeng Sun, Shrenik Mehta, Carolyn J. Adamski, Richard A. Gibbs, Timothy Palzkill	9
10	Removal of the Side Chain at the Active-Site Serine by a Glycine Substitution Increases the Stability of a Wide Range of Serine β-Lactamases by Relieving Steric Strain 2016 ·Biochemistry ·(unknown), Carolyn J. Adamski, Liya Hu, Shrenik Mehta, Banumathi Sankaran, Peter H. Zwart, B. V. Venkataram Prasad, Timothy Palzkill	19
11	Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability 2015 ·PLoS Pathogens ·Shrenik Mehta, (unknown), Timothy Palzkill	86
12	Crystal Structure of the cGMP-dependent Protein Kinase II Leucine Zipper and Rab11b Protein Complex Reveals Molecular Details of G-kinase-specific Interactions 2014 ·Journal of Biological Chemistry ·Albert S. Reger, (unknown), (unknown), (unknown), Shrenik Mehta, Keizo Yuasa, Alan Z. Liu, Darren E. Casteel, Choel Kim	17
13	PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates 2014 ·Antimicrobial Agents and Chemotherapy ·S. Wesley Long, Randall J. Olsen, Shrenik Mehta, Timothy Palzkill, Patricia L. Cernoch, Katherine K. Perez, William L. Musick, Adriana E. Rosato, James M. Musser	113
14	Discovery of Allosteric Modulators of Factor XIa by Targeting Hydrophobic Domains Adjacent to Its Heparin-Binding Site 2013 ·Journal of Medicinal Chemistry ·(unknown), Rami A. Al‐Horani, Shrenik Mehta, David Gailani, Umesh R. Desai	40
15	β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives 2012 ·Antimicrobial Agents and Chemotherapy ·Shrenik Mehta, Christopher R. Singh, Konrad Plata, Palas K. Chanda, (unknown), Sarah Riosa, Roberto R. Rosato, Adriana E. Rosato	113
16	VraSR Two-Component Regulatory System Contributes to mprF -Mediated Decreased Susceptibility to Daptomycin in In Vivo -Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus 2011 ·Antimicrobial Agents and Chemotherapy ·Shrenik Mehta, Arabela Cuirolo, Konrad Plata, Sarah Riosa, Jared Silverman, Aileen Rubio, Roberto R. Rosato, Adriana E. Rosato	102
17	Is methodology the highway out of verification hell? 2005 ·(unknown), (unknown), Harry Foster, Janick Bergeron, Masayuki NAKAMURA, Shrenik Mehta, (unknown)	3
18	[Synthesis of hydrogenated dipiperidazino-tetrazine, -tetrazepine- and -tetrazocine derivatives]. 1966 ·PubMed ·(unknown), (unknown), (unknown), Shrenik Mehta	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact